ERYTHROCIN (erythromycin lactobionate)
ERYTHROCIN is indicated for the treatment of Lower Respiratory Tract Infection; Mycoplasma Pneumoniae Infection; Skin and Skin Structure Infection; Diphtheria; Erythrasma.
How ERYTHROCIN Works
Erythromycin exerts its antibacterial effect by binding to the 50S ribosomal subunits of susceptible organisms, thereby inhibiting RNA-dependent protein synthesis. This action prevents bacterial growth and replication without affecting nucleic acid synthesis.
Details
- Status
- Discontinued
- First Approved
- 1964-06-25
- Routes
- INJECTION
- Dosage Forms
- INJECTABLE
ERYTHROCIN Approval History
What ERYTHROCIN Treats
5 indicationsERYTHROCIN is approved for 5 conditions since its original approval in 1964. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Lower Respiratory Tract Infection
- Mycoplasma Pneumoniae Infection
- Skin and Skin Structure Infection
- Diphtheria
- Erythrasma
ERYTHROCIN Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Direct competitors
Same target(s) AND same indication — head-to-head.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to ERYTHROCIN
3 of 20FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
1 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT02755064 | 08-008620 UL1TR000135 | Ph 1 | completed | Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
ERYTHROCIN FDA Label Details
Indications & Usage
FDA Label (PDF)ERYTHROCIN is indicated for the treatment of Lower Respiratory Tract Infection; Mycoplasma Pneumoniae Infection; Skin and Skin Structure Infection; Diphtheria; Erythrasma.
Track ERYTHROCIN with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.